-
Experts say President Trump's Thursday night speech -- and the tranche of newly unclassified documents that came with it -- provided no new evidence of fraud.
-
NPR's Leila Fadel talks to David Becker, an election law expert and executive director of The Center for Election Innovation & Research, about the president's speech on election integrity issues.
-
The family of Lorenzo Salgado Araujo held a public viewing Thursday evening. Salgado Araujo, a 52-year old father of three, was killed in an ICE traffic stop in Houston last week.
-
The U.S. struck bridges and a tower at a key Iranian port after Trump warned of attacks to force Iran to reopen the Strait of Hormuz, as Iran continued retaliatory strikes.
-
Leaders from roughly 60 countries gathered in Washington, DC, to discuss what top Trump administration officials are calling an urgent threat: far left terrorism.
-
One of the most anticipated releases of the summer, Christopher Nolan's "The Odyssey" brings the epic to IMAX screens and beyond. Pop Culture Happy Hour's Glen Weldon has thoughts.
-
The 1994 World Cup is universally credited with sparking a boom of interest in soccer in the U.S., from youth leagues to televised games to the formation of MLS. The league and its teams say 2026 will be another boom -- the only question is, how to harness it?
-
NPR's Frank Langfitt tries his hand at catching crabs on the Chesapeake Bay. Maryland has more than 5,000 commercial licenses, but tens of thousands more crab for fun.
-
In a primetime address Thursday night, President Trump raised familiar claims about election integrity just months ahead of a midterm election, where Republicans are expected to take losses.
-
NPR's A Martinez discusses President Trump's speech on election security with Connecticut Rep. Jim Himes, the ranking Democrat on the House Intelligence Committee.
-
President Trump's longtime teleprompter operator has been accused of profiting off of his access to the president's prepared remarks by placing bets on the prediction market site Kalshi.
-
The Food and Drug Administration has approved a powerful new kind of cholesterol-lowering drug.